Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CDW Corp. (CDW) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

CDW Corp. vs State Street SPDR S&P Biotech ETF — how do they compare? CDW Corp. trades at $135.37 (market cap $16.92B), while State Street SPDR S&P Biotech ETF trades at $158.07. The key difference: CDW Corp. pays a 1.86% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, CDW Corp. nearer its low. Which is the better fit depends on your goals.

CDWXBI
Market Cap
$16.92B
Sector
TechnologyBroad Market / Factor
52-Week High
$170.77$164.28
52-Week Low
$99.30$86.92
Enterprise Value
$22.52B
Dividend Yield
1.86%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CDW Corp.

CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.

Read more on CDW

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI